Participant flow

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer · Source last updated 2023-08-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   CHEMOTHERAPY (weeks 1-9, 14-22): Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 3 courses during weeks 1-9 and 14-22. RADIATION THERAPY (weeks 8-16): Patients undergo external beam pelvic radiation therapy once a day, 5 days a week for 5 weeks during weeks 8-13. Patients then undergo High Dose Rate (HDR) brachytherapy or Intensity-modulated Radiation Therapy (IMRT) once weekly during weeks 14-16. paclitaxel: Given IV carboplatin: Given IV external beam radiation therapy: Undergo external beam radiation therapy brachytherapy: Undergo HDR brachytherapy intensity-modulated radiation therapy: Undergo IMRT laboratory biomarker analysis: Correlative studies

   id

   FG000

   title

   Treatment (Paclitaxel, Carboplatin, Radiotherapy)

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         11

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         11

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

14 participants were enrolled into the study between 7/08/2011-3/8/2016. Three participants screen failed prior to consenting.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice